Last reviewed · How we verify

Tranexamic Acid Oral Product

Alejandro Reyes Sánchez · FDA-approved active Small molecule Quality 2/100

Tranexamic Acid Oral Product is a Small molecule drug developed by Alejandro Reyes Sánchez. It is currently FDA-approved. Also known as: TA.

At a glance

Generic nameTranexamic Acid Oral Product
Also known asTA
SponsorAlejandro Reyes Sánchez
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tranexamic Acid Oral Product

What is Tranexamic Acid Oral Product?

Tranexamic Acid Oral Product is a Small molecule drug developed by Alejandro Reyes Sánchez.

Who makes Tranexamic Acid Oral Product?

Tranexamic Acid Oral Product is developed and marketed by Alejandro Reyes Sánchez (see full Alejandro Reyes Sánchez pipeline at /company/alejandro-reyes-s-nchez).

Is Tranexamic Acid Oral Product also known as anything else?

Tranexamic Acid Oral Product is also known as TA.

What development phase is Tranexamic Acid Oral Product in?

Tranexamic Acid Oral Product is FDA-approved (marketed).

Related